Drugmakers request changes to FDA’s mass balance studies guidance
Regulatory NewsJoanne S. Eglovitch
Biologics/ biosimilars/ vaccinesBiotechnologyClinical TrialsComplianceNorth AmericaPharmaceuticalsRegulatory Intelligence/PolicyRegulatory NewsJoanne S. EglovitchBiologics/ biosimilars/ vaccinesBiotechnologyClinical TrialsComplianceNorth AmericaPharmaceuticalsRegulatory Intelligence/Policy